Back to today’s briefing

Story perspectives

Cambridge Startup Lila Sciences Raises $200M to Revolutionize Drug Development

3/14/2025

29 7

Summary

Story summary

Lila Sciences, a groundbreaking startup from Cambridge, is set to transform drug development through AI and automated laboratories. With a hefty $200 million in funding, the team, including renowned geneticist George Church, has rapidly developed innovative antibodies and materials. Their mission? To collaborate with biotech firms and supercharge scientific discovery and efficiency.

1 of 1

Story summary

Lila Sciences, a groundbreaking startup from Cambridge, is set to transform drug development through AI and automated laboratories. With a hefty $200 million in funding, the team, including renowned geneticist George Church, has rapidly developed innovative antibodies and materials. Their mission? To collaborate with biotech firms and supercharge scientific discovery and efficiency.